Tackling the Challenges: Outlining a Novel Molecule for the Treatment of FSGS
Time: 9:00 am
day: Conference Day Two
Details:
- Detailing a multicenter phase III FSGS trial and addressing the timeline challenges
- Improving the recruitment of patients and encouraging the involvement of paediatric patients
- Navigating the route towards surrogate endpoint validation
